FDA advisory panel votes against new use of AbbVie's Humira

[riky]

FDA advisory panel votes against new use of AbbVie's Humira

(Reuters) - An advisory panel to the U.S. Food and Drug Administration voted against approving AbbVie Inc's rheumatoid arthritis drug Humira for treating an inflammatory disease of the spine. The panel of independent advisors called for additional trials to prove the efficacy of the drug in treating early-stages of spondyloarthritis. The FDA will take the panel's 12 to 1 vote into consideration while deciding upon the final approval for this new use for the drug. Ahead of Tuesday's panel meet, FDA staff had put out documents questioning the design of the trial. ...

Source: You are not allowed to view links. Register or Login